Report Detail

1 Market Overview of Targeted Drug Delivery Device

  • 1.1 Targeted Drug Delivery Device Market Overview
    • 1.1.1 Targeted Drug Delivery Device Product Scope
    • 1.1.2 Market Status and Outlook
  • 1.2 Global Targeted Drug Delivery Device Market Size Overview by Region 2015 VS 2020 VS 2026
  • 1.3 Global Targeted Drug Delivery Device Market Size by Region (2015-2026)
  • 1.4 Global Targeted Drug Delivery Device Historic Market Size by Region (2015-2020)
  • 1.5 Global Targeted Drug Delivery Device Market Size Forecast by Region (2021-2026)
  • 1.6 Key Regions, Targeted Drug Delivery Device Market Size YoY Growth (2015-2026)
    • 1.6.1 North America Targeted Drug Delivery Device Market Size YoY Growth (2015-2026)
    • 1.6.2 Europe Targeted Drug Delivery Device Market Size YoY Growth (2015-2026)
    • 1.6.3 Asia-Pacific Targeted Drug Delivery Device Market Size YoY Growth (2015-2026)
    • 1.6.4 Latin America Targeted Drug Delivery Device Market Size YoY Growth (2015-2026)
    • 1.6.5 Middle East & Africa Targeted Drug Delivery Device Market Size YoY Growth (2015-2026)

2 Targeted Drug Delivery Device Market Overview by Type

  • 2.1 Global Targeted Drug Delivery Device Market Size by Type: 2015 VS 2020 VS 2026
  • 2.2 Global Targeted Drug Delivery Device Historic Market Size by Type (2015-2020)
  • 2.3 Global Targeted Drug Delivery Device Forecasted Market Size by Type (2021-2026)
  • 2.4 Eye
  • 2.5 Brain
  • 2.6 Heart
  • 2.7 Breast
  • 2.8 Abdomen
  • 2.9 Others

3 Targeted Drug Delivery Device Market Overview by Application

  • 3.1 Global Targeted Drug Delivery Device Market Size by Application: 2015 VS 2020 VS 2026
  • 3.2 Global Targeted Drug Delivery Device Historic Market Size by Application (2015-2020)
  • 3.3 Global Targeted Drug Delivery Device Forecasted Market Size by Application (2021-2026)
  • 3.4 Metabolic Disorder
  • 3.5 Ophthalmic Disease
  • 3.6 Oncological Disorder
  • 3.7 Neurological Disorder
  • 3.8 Cardiovascular Disorder
  • 3.9 Others

4 Global Targeted Drug Delivery Device Competition Analysis by Players

  • 4.1 Global Targeted Drug Delivery Device Market Size by Players (2015-2020)
  • 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Drug Delivery Device as of 2019)
  • 4.3 Date of Key Manufacturers Enter into Targeted Drug Delivery Device Market
  • 4.4 Global Top Players Targeted Drug Delivery Device Headquarters and Area Served
  • 4.5 Key Players Targeted Drug Delivery Device Product Solution and Service
  • 4.6 Competitive Status
    • 4.6.1 Targeted Drug Delivery Device Market Concentration Rate
    • 4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data

  • 5.1 4D Molecular Therapeutics
    • 5.1.1 4D Molecular Therapeutics Profile
    • 5.1.2 4D Molecular Therapeutics Main Business
    • 5.1.3 4D Molecular Therapeutics Targeted Drug Delivery Device Products, Services and Solutions
    • 5.1.4 4D Molecular Therapeutics Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.1.5 4D Molecular Therapeutics Recent Developments
  • 5.2 AbbVie
    • 5.2.1 AbbVie Profile
    • 5.2.2 AbbVie Main Business
    • 5.2.3 AbbVie Targeted Drug Delivery Device Products, Services and Solutions
    • 5.2.4 AbbVie Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.2.5 AbbVie Recent Developments
  • 5.3 Abeona Therapeutics
    • 5.5.1 Abeona Therapeutics Profile
    • 5.3.2 Abeona Therapeutics Main Business
    • 5.3.3 Abeona Therapeutics Targeted Drug Delivery Device Products, Services and Solutions
    • 5.3.4 Abeona Therapeutics Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.3.5 Advaxis Recent Developments
  • 5.4 Advaxis
    • 5.4.1 Advaxis Profile
    • 5.4.2 Advaxis Main Business
    • 5.4.3 Advaxis Targeted Drug Delivery Device Products, Services and Solutions
    • 5.4.4 Advaxis Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.4.5 Advaxis Recent Developments
  • 5.5 Alcyone Lifesciences
    • 5.5.1 Alcyone Lifesciences Profile
    • 5.5.2 Alcyone Lifesciences Main Business
    • 5.5.3 Alcyone Lifesciences Targeted Drug Delivery Device Products, Services and Solutions
    • 5.5.4 Alcyone Lifesciences Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.5.5 Alcyone Lifesciences Recent Developments
  • 5.6 AlphaVax
    • 5.6.1 AlphaVax Profile
    • 5.6.2 AlphaVax Main Business
    • 5.6.3 AlphaVax Targeted Drug Delivery Device Products, Services and Solutions
    • 5.6.4 AlphaVax Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.6.5 AlphaVax Recent Developments
  • 5.7 Amgen
    • 5.7.1 Amgen Profile
    • 5.7.2 Amgen Main Business
    • 5.7.3 Amgen Targeted Drug Delivery Device Products, Services and Solutions
    • 5.7.4 Amgen Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.7.5 Amgen Recent Developments
  • 5.8 Amicus Therapeutics
    • 5.8.1 Amicus Therapeutics Profile
    • 5.8.2 Amicus Therapeutics Main Business
    • 5.8.3 Amicus Therapeutics Targeted Drug Delivery Device Products, Services and Solutions
    • 5.8.4 Amicus Therapeutics Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.8.5 Amicus Therapeutics Recent Developments
  • 5.9 Anaeropharma Science
    • 5.9.1 Anaeropharma Science Profile
    • 5.9.2 Anaeropharma Science Main Business
    • 5.9.3 Anaeropharma Science Targeted Drug Delivery Device Products, Services and Solutions
    • 5.9.4 Anaeropharma Science Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.9.5 Anaeropharma Science Recent Developments
  • 5.10 AnGes
    • 5.10.1 AnGes Profile
    • 5.10.2 AnGes Main Business
    • 5.10.3 AnGes Targeted Drug Delivery Device Products, Services and Solutions
    • 5.10.4 AnGes Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.10.5 AnGes Recent Developments
  • 5.11 AskBio
    • 5.11.1 AskBio Profile
    • 5.11.2 AskBio Main Business
    • 5.11.3 AskBio Targeted Drug Delivery Device Products, Services and Solutions
    • 5.11.4 AskBio Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.11.5 AskBio Recent Developments
  • 5.12 Astellas Pharma
    • 5.12.1 Astellas Pharma Profile
    • 5.12.2 Astellas Pharma Main Business
    • 5.12.3 Astellas Pharma Targeted Drug Delivery Device Products, Services and Solutions
    • 5.12.4 Astellas Pharma Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.12.5 Astellas Pharma Recent Developments
  • 5.13 AstraZeneca
    • 5.13.1 AstraZeneca Profile
    • 5.13.2 AstraZeneca Main Business
    • 5.13.3 AstraZeneca Targeted Drug Delivery Device Products, Services and Solutions
    • 5.13.4 AstraZeneca Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.13.5 AstraZeneca Recent Developments
  • 5.14 Athersys
    • 5.14.1 Athersys Profile
    • 5.14.2 Athersys Main Business
    • 5.14.3 Athersys Targeted Drug Delivery Device Products, Services and Solutions
    • 5.14.4 Athersys Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.14.5 Athersys Recent Developments
  • 5.15 BioCardia
    • 5.15.1 BioCardia Profile
    • 5.15.2 BioCardia Main Business
    • 5.15.3 BioCardia Targeted Drug Delivery Device Products, Services and Solutions
    • 5.15.4 BioCardia Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.15.5 BioCardia Recent Developments
  • 5.16 Biogen
    • 5.16.1 Biogen Profile
    • 5.16.2 Biogen Main Business
    • 5.16.3 Biogen Targeted Drug Delivery Device Products, Services and Solutions
    • 5.16.4 Biogen Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.16.5 Biogen Recent Developments
  • 5.17 BioInvent
    • 5.17.1 BioInvent Profile
    • 5.17.2 BioInvent Main Business
    • 5.17.3 BioInvent Targeted Drug Delivery Device Products, Services and Solutions
    • 5.17.4 BioInvent Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.17.5 BioInvent Recent Developments
  • 5.18 BioRestorative Therapies
    • 5.18.1 BioRestorative Therapies Profile
    • 5.18.2 BioRestorative Therapies Main Business
    • 5.18.3 BioRestorative Therapies Targeted Drug Delivery Device Products, Services and Solutions
    • 5.18.4 BioRestorative Therapies Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.18.5 BioRestorative Therapies Recent Developments
  • 5.19 bluebird bio
    • 5.19.1 bluebird bio Profile
    • 5.19.2 bluebird bio Main Business
    • 5.19.3 bluebird bio Targeted Drug Delivery Device Products, Services and Solutions
    • 5.19.4 bluebird bio Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.19.5 bluebird bio Recent Developments
  • 5.20 Boston Scientific
    • 5.20.1 Boston Scientific Profile
    • 5.20.2 Boston Scientific Main Business
    • 5.20.3 Boston Scientific Targeted Drug Delivery Device Products, Services and Solutions
    • 5.20.4 Boston Scientific Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.20.5 Boston Scientific Recent Developments
  • 5.21 CellProthera
    • 5.21.1 CellProthera Profile
    • 5.21.2 CellProthera Main Business
    • 5.21.3 CellProthera Targeted Drug Delivery Device Products, Services and Solutions
    • 5.21.4 CellProthera Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.21.5 CellProthera Recent Developments
  • 5.22 Celsion
    • 5.22.1 Celsion Profile
    • 5.22.2 Celsion Main Business
    • 5.22.3 Celsion Targeted Drug Delivery Device Products, Services and Solutions
    • 5.22.4 Celsion Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.22.5 Celsion Recent Developments
  • 5.23 Celyad
    • 5.23.1 Celyad Profile
    • 5.23.2 Celyad Main Business
    • 5.23.3 Celyad Targeted Drug Delivery Device Products, Services and Solutions
    • 5.23.4 Celyad Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.23.5 Celyad Recent Developments
  • 5.24 Evonik
    • 5.24.1 Evonik Profile
    • 5.24.2 Evonik Main Business
    • 5.24.3 Evonik Targeted Drug Delivery Device Products, Services and Solutions
    • 5.24.4 Evonik Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.24.5 Evonik Recent Developments
  • 5.25 Kadimastem
    • 5.25.1 Kadimastem Profile
    • 5.25.2 Kadimastem Main Business
    • 5.25.3 Kadimastem Targeted Drug Delivery Device Products, Services and Solutions
    • 5.25.4 Kadimastem Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.25.5 Kadimastem Recent Developments
  • 5.26 Medtronic
    • 5.26.1 Medtronic Profile
    • 5.26.2 Medtronic Main Business
    • 5.26.3 Medtronic Targeted Drug Delivery Device Products, Services and Solutions
    • 5.26.4 Medtronic Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.26.5 Medtronic Recent Developments
  • 5.27 Novartis
    • 5.27.1 Novartis Profile
    • 5.27.2 Novartis Main Business
    • 5.27.3 Novartis Targeted Drug Delivery Device Products, Services and Solutions
    • 5.27.4 Novartis Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.27.5 Novartis Recent Developments
  • 5.28 Sanofi
    • 5.28.1 Sanofi Profile
    • 5.28.2 Sanofi Main Business
    • 5.28.3 Sanofi Targeted Drug Delivery Device Products, Services and Solutions
    • 5.28.4 Sanofi Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.28.5 Sanofi Recent Developments
  • 5.29 SOTIO
    • 5.29.1 SOTIO Profile
    • 5.29.2 SOTIO Main Business
    • 5.29.3 SOTIO Targeted Drug Delivery Device Products, Services and Solutions
    • 5.29.4 SOTIO Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.29.5 SOTIO Recent Developments
  • 5.30 Takeda
    • 5.30.1 Takeda Profile
    • 5.30.2 Takeda Main Business
    • 5.30.3 Takeda Targeted Drug Delivery Device Products, Services and Solutions
    • 5.30.4 Takeda Targeted Drug Delivery Device Revenue (US$ Million) & (2015-2020)
    • 5.30.5 Takeda Recent Developments

6 North America

  • 6.1 North America Targeted Drug Delivery Device Market Size by Country
  • 6.2 United States
  • 6.3 Canada

7 Europe

  • 7.1 Europe Targeted Drug Delivery Device Market Size by Country
  • 7.2 Germany
  • 7.3 France
  • 7.4 U.K.
  • 7.5 Italy
  • 7.6 Russia
  • 7.7 Nordic
  • 7.8 Rest of Europe

8 Asia-Pacific

  • 8.1 Asia-Pacific Targeted Drug Delivery Device Market Size by Region
  • 8.2 China
  • 8.3 Japan
  • 8.4 South Korea
  • 8.5 Southeast Asia
  • 8.6 India
  • 8.7 Australia
  • 8.8 Rest of Asia-Pacific

9 Latin America

  • 9.1 Latin America Targeted Drug Delivery Device Market Size by Country
  • 9.2 Mexico
  • 9.3 Brazil
  • 9.4 Rest of Latin America

10 Middle East & Africa

  • 10.1 Middle East & Africa Targeted Drug Delivery Device Market Size by Country
  • 10.2 Turkey
  • 10.3 Saudi Arabia
  • 10.4 UAE
  • 10.5 Rest of Middle East & Africa

11 Targeted Drug Delivery Device Market Dynamics

  • 11.1 Industry Trends
  • 11.2 Market Drivers
  • 11.3 Market Challenges
  • 11.4 Market Restraints

12 Research Finding /Conclusion

    13 Methodology and Data Source

    • 13.1 Methodology/Research Approach
      • 13.1.1 Research Programs/Design
      • 13.1.2 Market Size Estimation
      • 13.1.3 Market Breakdown and Data Triangulation
    • 13.2 Data Source
      • 13.2.1 Secondary Sources
      • 13.2.2 Primary Sources
    • 13.3 Disclaimer

    Targeted Drug Delivery Device is a method of delivery medication in some parts of the body. This means of delivery is largely founded on nanomedicine, which plans to employ nanoparticle-mediated drug delivery in order to combat the downfalls of conventional drug delivery. These nanoparticles would be loaded with drugs and targeted to specific parts where there is solely diseased tissue, thereby avoiding interaction with healthy tissue. The goal of the Targeted Drug Delivery is to prolong, localize, target and have a protected drug interaction with the diseased tissue. The conventional drug delivery system is the absorption of the drug across a biological membrane, whereas the targeted release system releases the drug in a dosage form. The advantages to the targeted release system is the reduction in the frequency of the dosages taken by the patient, having a more uniform effect of the drug, reduction of drug side-effects, and reduced fluctuation in circulating drug levels. The disadvantage of the system is high cost, which makes productivity more difficult and the reduced ability to adjust the dosages. (Wikipedia)

    Market Analysis and Insights: Global Targeted Drug Delivery Device Market
    The research report studies the Targeted Drug Delivery Device market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
    The global Targeted Drug Delivery Device market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
    Global Targeted Drug Delivery Device Scope and Segment
    The global Targeted Drug Delivery Device market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Targeted Drug Delivery Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
    by Type, the market is primarily split into
    by Target Organ
    Eye
    Brain
    Heart
    Breast
    Abdomen
    Others
    by Type of Biologic Delivered
    Cell
    Protein
    Enzyme
    Plasmid
    Antibody
    Small Peptide
    Modified RNA
    Growth Factor
    Neurotransmitter
    by Therapy Delivered
    Cell Therapy
    RNA Therapy
    Gene Therapy
    Immunotherapy
    Stem Cell Therapy
    by Application, this report covers the following segments
    Metabolic Disorder
    Ophthalmic Disease
    Oncological Disorder
    Neurological Disorder
    Cardiovascular Disorder
    Others
    Global Targeted Drug Delivery Device market: regional analysis, the major regions covered in the report are:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa
    The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
    The Targeted Drug Delivery Device key players in this market include:
    4D Molecular Therapeutics
    AbbVie
    Abeona Therapeutics
    Advaxis
    Alcyone Lifesciences
    AlphaVax
    Amgen
    Amicus Therapeutics
    Anaeropharma Science
    AnGes
    AskBio
    Astellas Pharma
    AstraZeneca
    Athersys
    BioCardia
    Biogen
    BioInvent
    BioRestorative Therapies
    bluebird bio
    Boston Scientific
    CellProthera
    Celsion
    Celyad
    Evonik
    Kadimastem
    Medtronic
    Novartis
    Sanofi
    SOTIO
    Takeda


    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Targeted Drug Delivery Device. Industry analysis & Market Report on COVID-19 Impact on Global Targeted Drug Delivery Device is a syndicated market report, published as COVID-19 Impact on Global Targeted Drug Delivery Device Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Targeted Drug Delivery Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,500.00
    $7,000.00
    2,622.13
    5,244.25
    2,949.73
    5,899.47
    364,031.50
    728,063.00
    259,338.80
    518,677.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report